Insperity Q3 net loss $20M, adj EPS ($0.20); extends UHC deal with $500k pooling cap through 2028

INSPERITY, INC.

2025-Q3 EPS reported $0.69 revenue$5,144,000,000

Q3 revenues $1.6B (+4% YoY); net loss $20M; GAAP EPS ($0.53); adjusted EPS ($0.20).
Healthcare costs drove 15% gross profit decline to $195M; elevated inpatient/outpatient/pharmacy trends cited.
New UnitedHealthcare contract extends through 2028, reduces large-claim pooling to $500k from Jan 2026, adds volume incentives.
YTD net income $26M ($0.69 EPS); adjusted EBITDA $144M; returned $87M to shareholders via buybacks and dividends.
HRScale (Insperity/Workday) product rollout underway; Workday costs $38M YTD.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.